Head to head
Cimpress vs Cintas
Side-by-side on the measures that matter, with a plain-English read. Full detail: CMPR · CTAS
CMPR
Cimpress
53.81-0.79%
1-year price shape — -19% over the period
Quant Rating D · 20/100
vs
CTAS
Cintas
220.01+0.50%
1-year price shape — +21% over the period
Quant Rating C · 66/100
1-year performance, rebased to 100
Cintas edges it on the scoreable measures. Cintas has the highest Quant Rating (66); Cintas has done best over the past year (+21%); Cintas pays the highest dividend yield.
| CMPR | CTAS | |
|---|---|---|
| Snapshot | ||
| Sector | Specialty Business Services | Specialty Business Services |
| Last price | 53.81 | 220.01 |
| Change today | -0.79% | +0.50% |
| 1-year return | -18.5% | +21.0% |
| Market cap | $1.32B | $87.36B |
| 52-week range | 52.72 – 106.58 | 159.94 – 232.93 |
| Valuation | ||
| P/E (TTM) | 15.92 | 43.39 |
| P/E percentile, own 5-yr range | 65th | 65th |
| P/B | -2.65 | 16.79 |
| Dividend yield | 0.00% | 0.85% |
| Profitability & growth | ||
| EPS (TTM) | 3.79 | 4.91 |
| Net profit (TTM) | $93.31M | $1.95B |
| Revenue (TTM) | $3.81B | $11.56B |
| Provider revenue period date | 2026-09-29 | 2026-08-30 |
| Revenue growth (YoY) | +8.2% | +10.9% |
| Gross margin | 45.6% | 51.0% |
| Operating margin | 6.3% | 23.6% |
| Net margin | 2.2% | 17.8% |
| Free cash flow (TTM) | $124.69M | $2.03B |
| Provider cash-flow period date | 2026-09-29 | 2026-08-30 |
| Ownership & sentiment | ||
| Institutional ownership | 92.3% | 69.3% |
| Insider activity (12mo) | 26 buy / 24 sell | 41 buy / 9 sell |
| Short interest (% of float) | 8.6% | 2.6% |
| Analyst consensus | 100% buy (2) | 64% buy / 29% hold / 7% sell (14) |
| Analyst price target | $96 (+78%) | $225 (+2%) |
| StockVane view | ||
| StockVane Quant Rating | D (20) | C (66) |
| Company | ||
| Employees | 16,500 | 48,100 |
| Founded | 2017 | 1968 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.